Fernando Cura

ORCID: 0000-0002-1664-8923
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Infective Endocarditis Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Health and Mental Health
  • Aortic Disease and Treatment Approaches
  • Peripheral Artery Disease Management
  • Atrial Fibrillation Management and Outcomes
  • Vascular Procedures and Complications
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Structural Anomalies and Repair
  • Aortic aneurysm repair treatments
  • Cardiomyopathy and Myosin Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Effects of Exercise
  • Cardiac Arrhythmias and Treatments
  • Central Venous Catheters and Hemodialysis
  • Cardiac tumors and thrombi
  • Cardiovascular Function and Risk Factors
  • Renal and Vascular Pathologies
  • Heart Failure Treatment and Management

Instituto Cardiovascular de Buenos Aires
2011-2024

Universidade de São Paulo
2021

Florida College
2011

VA Boston Healthcare System
2011

Brigham and Women's Hospital
2011

Harefield Hospital
2011

Thrombolysis in Myocardial Infarction Study Group
2011

Tokai University
2011

University College Dublin
2011

Jagiellonian University
2011

Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI).In this double-blind, placebo-controlled study, we randomly assigned 5362 patients who had not been treated with clopidogrel to receive either cangrelor or placebo at the time of PCI, followed by 600 mg clopidogrel. The primary end point was composite death, myocardial infarction, ischemia-driven revascularization 48...

10.1056/nejmoa0908629 article EN New England Journal of Medicine 2009-11-15

Thrombin is a key mediator of platelet activation. Atopaxar reversible protease-activated receptor-1 antagonist that interferes with thrombin-mediated effects. The phase II Lessons From Antagonizing the Cellular Effect Thrombin-Coronary Artery Disease (LANCELOT-CAD) trial examined safety and tolerability prolonged therapy atopaxar in subjects CAD.Subjects qualifying history were randomized double-blind fashion to 3 dosing regimens (50, 100, or 200 mg daily) matching placebo for 24 weeks...

10.1161/circulationaha.110.001404 article EN Circulation 2011-04-19

Introducción: El acceso radial se ha asociado a numerosos beneficios en angioplastia coronaria comparación con el femoral. Sin embargo, múltiples registros internacionales han reportado una escasa adherencia esta técnica. Objetivos: Evaluar la seguridad, eficacia y eficiencia operativa de según vía utilizada cuadro clínico del paciente. Métodos:Análisis registro,unicéntrico retrospectivo los pacientes enfermedad tratados desde marzo 2009 junio 2018,según vascular.Se aplicó un modelo...

10.7775/rac.es.v87.i1.13846 article ES Revista Argentina de Cardiología 2025-05-07

Background: The safety and efficacy of antithrombotic regimens may differ between patients with atrial fibrillation who have acute coronary syndromes (ACS), treated medically or percutaneous intervention (PCI), those undergoing elective PCI. Methods: Using a 2×2 factorial design, we compared apixaban vitamin K antagonists aspirin placebo in had ACS were PCI receiving P2Y 12 inhibitor. We explored bleeding, death hospitalization, as well ischemic events, by strategy 3 prespecified subgroups:...

10.1161/circulationaha.119.043308 article EN Circulation 2019-09-26
Antonio Landi Mirvat Alasnag Dik Heg Enrico Frigoli Fazila‐Tun‐Nesa Malik and 95 more Iván Gómez‐Blázquez Suzanne Pourbaix Alaide Chieffo Christian Spaulding Fermín Sáinz Helen Routledge Giuseppe Andò Luca Testa Alessandro Sciahbasi Hussain Contractor Nigel Jepson Juan Mieres Syed Saqib Imran Husam A. Noor Pieter C. Smits Marco Valgimigli Marco Valgimigli Peter C. Smits Gabriélian Es G.B.W.E. Vos Ernest Spitzer Pascal Vrancks Bernard Chevalier Yukio Ozaki Marie‐Claude Morice Stephan Windecker Yoshinobu Onuma Enrico Frigoli Andrè Frenk Peter C. Jüni Jan G.P. Tijssen Dragica Paunovic Mullasari S. Ajit Mirvat Alasnag Jozef Bartúnek Antonio Colombo David Hildick‐Smith Andrés Íñiguez Felix Mahfoud Ran Kornowski Maciej Lesiak Paul Jau Lueng Ong Alfredo E. Rodríguez Marco Roffi Carl Schultz Goran Stanković Pim A.L. Tonino Aris Moschovitis Peep Laanmets Michael Donahue M Bertrand Stuart J. Pocock Philip Urban Sergio Leonardi Claude Hanet Renato D. Lópes Eugène McFadden Peter W. Radke Risto O. Roine Boudijn Ladan Laura van der Waal Yvonne Engelbrecht Fred Paddenburg Ben Ren Ingrid de Zwart Liliane Elshout Judith Jonk Tessa Rademaker‐Havinga Ria van Vliet Phani Krishna Kondamudi Laure Morsiani U. Windhövel Anita van der Wal C.D. Bakker Kazuhiro Minagawa Juan Mieres Fernando Cura Carlos Fernández‐Pereira A. Lee Nigel Jepson Robert Whitbourn O. Raffel Kurt Huber Franz Weidinger Fazila-Tun-Nesa Malik Hasselt Jessa Ziekenhuis Imelda Ziekenhuis Willem Dewilde Adel Aminian Emanuele Aalst Suzanne Pourbaix Panagiotis Xaplanteris Vasil Velchev Dimitar Karageorgiev Hristo Mateev

Importance Abbreviated dual antiplatelet therapy (DAPT) reduces bleeding with no increase in ischemic events patients at high risk (HBR) undergoing percutaneous coronary intervention (PCI). Objectives To evaluate the association of sex comparative effectiveness abbreviated vs standard DAPT HBR. Design, Setting, and Patients This prespecified subgroup analysis followed Management High Bleeding Risk Post Bioresorbable Polymer Coated Stent Implantation With an Standard Regimen (MASTER DAPT)...

10.1001/jamacardio.2023.4316 article EN JAMA Cardiology 2023-11-22
Muthiah Vaduganathan Robert A. Harrington Gregg W. Stone Efthymios Deliargyris Philippe Gabríel Steg and 95 more C. Michael Gibson Christian W. Hamm Matthew J. Price Alberto Menozzi Jayne Prats Steven Elkin Kenneth W. Mahaffey Harvey D. White Deepak L. Bhatt Fernando Cura M Ballarino Aníbal Damonte Diego Grinfeld Carlos Alejandro Álvarez Alberto Ocaña A. Farshid Brendan Gunalingam Craig Jeurgens Harry C. Lowe H. Hallani G. Nelson Gishel New Ronald Dick Jeffrey Lefkovits Stephen W. Duffy Nick Bett Raibhan Yadav P. Garrahy Ron Lehman Philip E. Aylward John D. Horowitz M. Worthley D. Cross Jaime Rankin Peter Thompson Phil Roberts-Thomson D. Cross Rohan Jayasinghe Con Aroney Kurt Huber F Leisch Johann Altenberger Georg Gaul Thomas Neunteufl Franz Weidinger Herwig Schuchlenz H. Wéber Werner Benzer Paulo Roberto Ferreira ROSSI Breno Oliveira Almeida Antônio Francisco Godinho Fábio Vilas‐Boas Luciano Janussi Vacanti Renato Giestas Serpa José Antonio Jatene Gilmar Reis Jamil Abdalla Saad Marcos Maynar-Mariño Roberto Botelho Constantino Costantini Ricardo Wang Dalton Bertolim Précoma M Rati L. C. Bodanese Euler Roberto Fernandes Manenti João Paulo Zouvi Rogério Tumelero Arthur Herdy Eulógio Martinez Filho Antônio Carlos Carvalho Roberto Alexandre Franken Lawrence Title Charles Lazzam François Reeves Tamaz Shaburishvili Gulnara Chapidze Merab Mamatsashvili Irakli Khintibidze Kurt Huber Hans‐Georg Olbrich Sabine Genth‐Zotz S Moebius-Winkler Michael Buerke Stefan Hoffmann Peter W. Radke Helge Moellmann Hugo A. Katus HANS-FRIEDRICH VOEHRINGER Christian Hengstenberg Volker Klauß Johannes Brachmann Aftab Ahmad Khan Sampath Kumar P.P. Mohanan Praveen Chandra

10.1016/j.jacc.2016.10.055 article EN Journal of the American College of Cardiology 2017-01-01

Previous trials testing stents compared with balloon angioplasty excluded patients complex lesions and did not assess the effect of adjunctive platelet IIb/IIIa inhibition. This analysis sought to stenting abciximab specifically for lesions.Patients (long, tandem, severely calcified, restenotic, thrombotic, or ostial; total occlusions; bifurcations; saphenous vein grafts; multivessel interventions) from Evaluation PTCA Improve Long-Term Outcome by c7E3 GP Receptor Blockade (EPILOG) Platelet...

10.1161/01.cir.102.1.28 article EN Circulation 2000-07-04

Objective Cigarette smokers have an unexplained low mortality following ST-segment elevation acute myocardial infarction (STEMI). Our aim was to determine whether the presence of active smoking has a beneficial effect on reperfusion primary percutaneous intervention (PCI). Methods A total 140 STEMI patients treated with PCI were included in analysis. All 24-h monitoring, each analyzed by independent, blinded core laboratory. We divided population according status: (n = 56) and nonactive 84)....

10.2459/jcm.0b013e3282f73519 article EN Journal of Cardiovascular Medicine 2008-08-01

Background No study has evaluated the impact of additional manipulation demanded by multiple resheathing (MR) in patients undergoing transcatheter aortic valve replacement with repositionable self-expanding valves. Methods and Results This included a real-world, multicenter registry involving 16 centers from Canada, Germany, Latin America, Spain. All consecutive who underwent Evolut R, PRO, Portico valves were included. Patients divided according to number resheathing: no resheathing, single...

10.1161/jaha.120.020682 article EN cc-by-nc-nd Journal of the American Heart Association 2021-09-03

Inadequate stent implantation is associated with thrombosis and restenosis. StentBoost can enhance visualization evaluate expansion. Currently, there are limited comparison studies between intravascular ultrasound (IVUS). We aimed to test the correlation agreement IVUS measurements. From December 2010 2011, 38 patients (54 stents) were analyzed using StentBoost. Minimal diameter proximal distal edge compared imaging techniques Pearson Bland–Altman scatter plot. There was good measurements...

10.1007/s40119-013-0023-2 article EN cc-by-nc Cardiology and Therapy 2013-12-01

The aim of this study was to determine whether the presence collateral circulation had a beneficial effect following primary angioplasty. In all, 114 patients who underwent angioplasty were included. Patients with lower basal ST-segment deviation (P = .004), white cell count ( P .001), peak creatine kinase and regional wall motion score values .03) than without circulation. After procedure, group collaterals associated higher rates normal myocardial blush, complete ST resolution, shorter...

10.1177/0003319707308725 article EN Angiology 2008-04-04

INTRODUÇÃO: A magnitude da resolução do supradesnivelamento segmento ST é um marcador de reperfusão miocárdica em pacientes com infarto agudo miocárdio. incompleta foi identificada como preditor resultados desfavoráveis miocárdio após terapia reperfusão. Este estudo teve objetivos descrever a frequência registro contemporâneo submetidos angioplastia primária e fazer uma comparação seus hospitalares que apresentaram completa ST. MÉTODO: Entre julho 2008 fevereiro 2009, foram incluídos 183...

10.1590/s2179-83972009000400009 article PT cc-by-nc Revista Brasileira de Cardiologia Invasiva 2009-01-01

Nonagenarians are mostly denied from different therapeutic strategies due to high preoperative risk. We present the results of nonagenarians with severe aortic stenosis (AS) undergoing transcatheter valve replacement (TAVR).Our retrospective analysis include baseline and procedural data along clinical outcome. Clinical follow-up was performed in all patients after TAVR.Out 689 patients, 33 a mean age 90.9±1.4years suffering AS elevated comorbidity index (logistic EuroSCORE 16.3±9.6%, STS...

10.1016/j.ihj.2017.02.017 article EN cc-by-nc-nd Indian Heart Journal 2017-03-06
Coming Soon ...